These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27446329)

  • 1. Resveratrol inhibits doxorubicin-induced cardiotoxicity via sirtuin 1 activation in H9c2 cardiomyocytes.
    Liu MH; Shan J; Li J; Zhang Y; Lin XL
    Exp Ther Med; 2016 Aug; 12(2):1113-1118. PubMed ID: 27446329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hesperetin Alleviates Doxorubicin-Induced Cytotoxicity in H9c2 Cells by Activating SIRT1/NRF2 Signaling].
    Li X; Yan A; Chang J; Li F; Zhu J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Sep; 54(5):947-953. PubMed ID: 37866951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrogen sulfide protects H9c2 cardiac cells against doxorubicin-induced cytotoxicity through the PI3K/Akt/FoxO3a pathway.
    Liu MH; Zhang Y; He J; Tan TP; Wu SJ; Guo DM; He H; Peng J; Tang ZH; Jiang ZS
    Int J Mol Med; 2016 Jun; 37(6):1661-8. PubMed ID: 27081862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol protects cardiomyocytes from doxorubicin-induced apoptosis through the AMPK/P53 pathway.
    Liu MH; Lin XL; Guo DM; Zhang Y; Yuan C; Tan TP; Chen YD; Wu SJ; Ye ZF; He J
    Mol Med Rep; 2016 Feb; 13(2):1281-6. PubMed ID: 26675978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol prevents doxorubicin-induced cardiotoxicity in H9c2 cells through the inhibition of endoplasmic reticulum stress and the activation of the Sirt1 pathway.
    Lou Y; Wang Z; Xu Y; Zhou P; Cao J; Li Y; Chen Y; Sun J; Fu L
    Int J Mol Med; 2015 Sep; 36(3):873-80. PubMed ID: 26202177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol protects against doxorubicin-induced cardiotoxicity by attenuating ferroptosis through modulating the MAPK signaling pathway.
    Chen L; Sun X; Wang Z; Chen M; He Y; Zhang H; Han D; Zheng L
    Toxicol Appl Pharmacol; 2024 Jan; 482():116794. PubMed ID: 38142782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous hydrogen sulfide protects against doxorubicin-induced inflammation and cytotoxicity by inhibiting p38MAPK/NFκB pathway in H9c2 cardiac cells.
    Guo R; Wu K; Chen J; Mo L; Hua X; Zheng D; Chen P; Chen G; Xu W; Feng J
    Cell Physiol Biochem; 2013; 32(6):1668-80. PubMed ID: 24356372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol and FGF1 Synergistically Ameliorates Doxorubicin-Induced Cardiotoxicity via Activation of SIRT1-NRF2 Pathway.
    Lu G; Liu Q; Gao T; Li J; Zhang J; Chen O; Cao C; Mao M; Xiao M; Zhang X; Wang J; Guo Y; Tang Y; Gu J
    Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvianolic Acid A Protects H9C2 Cardiomyocytes from Doxorubicin-Induced Damage by Inhibiting NFKB1 Expression Thereby Downregulating Long-Noncoding RNA (lncRNA) Plasmacytoma Variant Translocation 1 (PVT1).
    Wu Y; Xiu W; Wu Y
    Med Sci Monit; 2021 Jun; 27():e929824. PubMed ID: 34153024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in mice through SIRT1-mediated deacetylation of p53.
    Zhang C; Feng Y; Qu S; Wei X; Zhu H; Luo Q; Liu M; Chen G; Xiao X
    Cardiovasc Res; 2011 Jun; 90(3):538-45. PubMed ID: 21278141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sesamin ameliorates doxorubicin-induced cardiotoxicity: involvement of Sirt1 and Mn-SOD pathway.
    Su S; Li Q; Liu Y; Xiong C; Li J; Zhang R; Niu Y; Zhao L; Wang Y; Guo H
    Toxicol Lett; 2014 Jan; 224(2):257-63. PubMed ID: 24211423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycyrrhizin improved autophagy flux via HMGB1-dependent Akt/mTOR signaling pathway to prevent Doxorubicin-induced cardiotoxicity.
    Lv X; Zhu Y; Deng Y; Zhang S; Zhang Q; Zhao B; Li G
    Toxicology; 2020 Aug; 441():152508. PubMed ID: 32525084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berberine Ameliorates Doxorubicin-Induced Cardiotoxicity via a SIRT1/p66Shc-Mediated Pathway.
    Wu YZ; Zhang L; Wu ZX; Shan TT; Xiong C
    Oxid Med Cell Longev; 2019; 2019():2150394. PubMed ID: 31885776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibition of the p38 MAPK pathway in H9c2 cells.
    Guo R; Lin J; Xu W; Shen N; Mo L; Zhang C; Feng J
    Int J Mol Med; 2013 Mar; 31(3):644-50. PubMed ID: 23338126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulating basal mitochondrial respiration decreases doxorubicin apoptotic signaling in H9c2 cardiomyoblasts.
    Deus CM; Zehowski C; Nordgren K; Wallace KB; Skildum A; Oliveira PJ
    Toxicology; 2015 Aug; 334():1-11. PubMed ID: 25997894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diethyl Blechnic, a Novel Natural Product Isolated from
    Yu J; Gao H; Wu C; Xu QM; Lu JJ; Chen X
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29921821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective Effects of Dioscin Against Doxorubicin-Induced Hepatotoxicity
    Song S; Chu L; Liang H; Chen J; Liang J; Huang Z; Zhang B; Chen X
    Front Pharmacol; 2019; 10():1030. PubMed ID: 31572199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of peroxiredoxin III in doxorubicin-induced cytotoxicity and the FoxO3a-dependent expression in H9c2 cardiac cells.
    Liu MH; Zhang Y; He J; Tan TP; Wu SJ; Fu HY; Chen YD; Liu J; LE QF; Hu HJ; Yuan C; Lin XL
    Exp Ther Med; 2015 Oct; 10(4):1515-1520. PubMed ID: 26622517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac SIRT1 ameliorates doxorubicin-induced cardiotoxicity by targeting sestrin 2.
    Wang A J; Tang Y; Zhang J; Wang B J; Xiao M; Lu G; Li J; Liu Q; Guo Y; Gu J
    Redox Biol; 2022 Jun; 52():102310. PubMed ID: 35452917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibiting the expression of peroxiredoxin III in H9c2 cells.
    Liu MH; Lin XL; Yuan C; He J; Tan TP; Wu SJ; Yu S; Chen L; Liu J; Tian W; Chen YD; Fu HY; Li J; Zhang Y
    Mol Med Rep; 2016 Jan; 13(1):367-72. PubMed ID: 26573464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.